Music |
Video |
Movies |
Chart |
Show |
Practice Changing Updates: The Evolving Treatment Landscape in Hemophilia A - Episode 1 (Practice Point Communications) View | |
Episode 1: Recognizing Rare Diseases in the United States (AJMCtv) View | |
Intellia Therapeutics CRISPR Genome Editing Treatment for ATTR (Amyloidosis Support Groups) View | |
Prompt ITI (WFHcommunications) View | |
Seligsohn Memorials' | 08\10 Emerging options for hemophilia treatment in the new era - Gili Kenet (The Israel Academy of Sciences and Humanities) View | |
Episode 3 - Patient-Centered Approaches to Long-Term Prophylaxis in HAE (Practice Point Communications) View | |
Episode 18 - The Role of Specialty Pharmacies in Rare Diseases (AJMCtv) View | |
Debate: Should JAK2 inhibitors be used for lower-risk MF, or only on-label (higher-risk) - Yes (HMP Education) View | |
Evolution of Health Communication (manoj raghav) View | |
Peter Marks: The Regulatory Landscape for Genome Editing (NAS Colloquia) View |